Schedule 13D ownership disclosure

SATSUMA PHARMACEUTICALS INC

Security class unavailable · CUSIP: 80405P107

Event date: 2019-09-17

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,681,858
Percent of class
28.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-19-044922
Form type
SC 13D
Filer
RA CAPITAL MANAGEMENT, L.P.
CIK
CIK 1346824
Filed
Sep 17, 2019
Reporting period
Sep 17, 2019
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub